Renate E. van Genugten

Author

Amsterdam UMC Location Vrije Universiteit Amsterdam

Also Known As

R. E. van Genugten, R.E. van Genugten, Renate E van Genugten, Renate E. van Genugten

Publications

545

Citations

H-Index

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam National Research Council Deutsches Diabetes-Zentrum e.V.

About

Renate E. van Genugten is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, metabolic syndrome, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	155
2	Diabetes	4	4	141
3	Health Sciences	3	3	115
4	Endocrinology	2	2	101
5	Cell Biology	1	1	14

Renate E. van Genugten

Publications

423

Citations

H-Index

Page 1

	Year	Citations
Glucagon-Like Peptide-1 Receptor Agonist Treatment Prevents Glucocorticoid-Induced Glucose Intolerance and Islet-Cell Dysfunction in Humans Daniël H. van Raalte, Renate E. van Genugten, Margot M. Linssen, Diabetes Care	2011	147
Effects of Sex and Hormone Replacement Therapy Use on the Prevalence of Isolated Impaired Fasting Glucose and Isolated Impaired Glucose Tolerance in Subjects With a Family History of Type 2 Diabetes Renate E. van Genugten, Kristina M. Utzschneider, Jenny Tong, Diabetes Family MedicineGynecologyFamily HistoryGlucose ToleranceObesity	2006	69
Does dipeptidyl peptidase-4 inhibition prevent the diabetogenic effects of glucocorticoids in men with the metabolic syndrome? A randomized controlled trial Renate E. van Genugten, Daniël H. van Raalte, Marcel H.A. Muskiet, European Journal of Endocrinology	2013	47
The effect of alogliptin and pioglitazone combination therapy on various aspects of β-cell function in patients with recent-onset type 2 diabetes Daniël H. van Raalte, Renate E. van Genugten, Björn Eliasson, European Journal of Endocrinology	2014	46
Islet-cell dysfunction induced by glucocorticoid treatment: potential role for altered sympathovagal balance? Daniël H. van Raalte, Kelly A.A. Kwa, Renate E. van Genugten, Metabolism Metabolic SyndromeInsulin SignalingMedicineInsulin ManagementPhysiology	2012	32
Metabolic changes in type 2 diabetes are reflected in peripheral blood cells, revealing aberrant cytotoxicity, a viral signature, and hypoxia inducible factor activity Tineke C. T. M. van der Pouw Kraan, Weena J. Chen, Mathijs C. Bunck, BMC Medical Genomics	2015	28
Does glucagon-like peptide-1 receptor agonist therapy add value in the treatment of type 2 diabetes? Focus on exenatide Renate E. van Genugten, Daniël H. van Raalte, Michaëla Diamant Diabetes Research and Clinical Practice Metabolic SyndromeDiabetes ManagementDiabetesPharmacologyType 2	2009	26
Palmitic acid increases pro-oxidant adaptor protein p66Shc expression and affects vascularization factors in angiogenic mononuclear cells: Action of resveratrol Julie Favre, Cansu Yıldırım, Thomas A. Leyen, Vascular Pharmacology InflammationAngiogenesisMedicineVascular AdaptationPhysiology	2015	14
Postprandial microvascular function deteriorates in parallel with gradual worsening of insulin sensitivity and glucose tolerance in men with the metabolic syndrome or type 2 diabetes Renate E. van Genugten, Erik H. Serné, Martijn W. Heymans, Diabetologia ObesityMetabolic SyndromeCardiovascular DiseaseMedicinePhysiology	2012	14

Page 1